Skip to Content

MYLAN 2250 MYLAN 2250 (Mycophenolate Mofetil 250 mg)

Pill with imprint MYLAN 2250 MYLAN 2250 is Tan / Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2250 MYLAN 2250

Mycophenolate mofetil 250 mg MYLAN 2250 MYLAN 2250
Mycophenolate mofetil 250 mg MYLAN 2250 MYLAN 2250
Mycophenolate mofetil 250 mg MYLAN 2250 MYLAN 2250
Mycophenolate mofetil 250 mg MYLAN 2250 MYLAN 2250

Mycophenolate Mofetil

Imprint
MYLAN 2250 MYLAN 2250
Strength
250 mg
Color
Tan / Purple
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate, ferrosoferric oxide, FD&C Blue No. 2, gelatin, ferric oxide red, titanium dioxide, ferric oxide yellow, ammonia, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-2250 Mylan Pharmaceuticals Inc.
51079-0721 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.